GlassScriptPhysician profile
Daisy Lazarous
NPI 1952397382
$12,689.14
in general payments reported to CMS, 2019-2025
36 companies · $1,493 in 2025
The $1,493 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $2,899 · 2021: $3,855 · 2022: $1,397 · 2023: $1,384 · 2024: $1,098 · 2025: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,956 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,955.61 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,918.64 | 2019-2025 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $759.96 | 2019-2025 | |
| Pfizer INC. | $729.43 | 2019-2025 | |
| Amgen INC. | $527.58 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $512.24 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $445.68 | 2021-2025 | Watchman, Watchman Flx, Bodyguardian |
| Bayer Healthcare Pharmaceuticals INC. | $408.46 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $382.43 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $378.85 | 2019-2024 | Xarelto |
| Philips North America LLC | $349.58 | 2022-2025 | (Ck4) Mcot, Mcot, Ecc Solutions |
| Amarin Pharma, INC. | $253.79 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.96 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.41 | 2019-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $171.53 | 2022-2025 | Amvuttra |
| Esperion Therapeutics, INC. | $170.53 | 2020-2025 | Nexletol |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $146.99 | 2019-2025 | Opsumit, Opsynvi |
| Baxter Healthcare | $130.39 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $126.58 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Preventice Services, LLC | $91.30 | 2021 | |
| Irhythm Technologies, INC. | $85.46 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $79.95 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $66.11 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $64.32 | 2019-2024 | Evkeeza |
| Kiniksa Pharmaceuticals, LTD. | $61.26 | 2023 | Arcalyst |
| Atricure, INC. | $61.12 | 2022-2024 | |
| Astellas Pharma US INC | $57.86 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $44.66 | 2019 | |
| Scpharmaceuticals INC. | $35.64 | 2025 | |
| Mannkind Corporation | $29.00 | 2025 | |
| Daiichi Sankyo INC. | $27.40 | 2025 | Injectafer |
| Inspire Medical Systems, INC. | $25.11 | 2025 | Inspire |
| Braemar Manufacturing, LLC | $21.71 | 2019 | |
| Vital Connect, INC | $20.95 | 2023 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $20.45 | 2024 | Assure Wcd |
| Medicomp INC | $18.80 | 2025 | Telepatch Cardiac Monitor |
| Stryker Corporation | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daisy Lazarous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.